On September 23rd, Qitan Tech, a company invested by ZGC Development Group, launched the high-throughput nanopore gene sequencer——QPinnacle2. This move signals that Qitan Tech has become one of the few domestic enterprises capable of manufacturing low, medium and high-throughput nanopore gene sequencers. It also marks that domestic gene sequencers have entered the international advanced ranks in terms of throughput, accuracy and stability.

The QPinnacle2 high-throughput sequencer is equipped with two chips that operate independently. Each chip can produce 400Gb of data, and the overall throughput of the device reaches 800Gb. It can better support big-data application scenarios such as human genome research, population cohort screening, and animal and plant breeding. Its O2 biochemical system has, for the first time, raised the accuracy rate of domestic nanopore sequencing to 99%, greatly enhancing the data reliability.

As a leading enterprise in the new generation of gene sequencing, Qitan Tech is committed to the independent R&D, manufacturing and application development of nanopore gene sequencers and their supporting chips and reagents. Since launching China's first nanopore gene sequencer in 2021, the company has been iterating its major products every two years, gradually breaking the long-term monopoly of foreign enterprises in the field of new-generation gene sequencing equipment.

In addition to technological breakthroughs, the company has also made solid progress in industrialization and ecological construction. As of now, Qitan Tech's QNome low-throughput sequencing platform has served over 300 users, and its QPursue medium-throughput sequencing platform over 200 users. Covering multiple fields such as scientific research, medical care, public health, and agriculture, these platforms support numerous applications including pathogen detection, genetic disease screening, environmental monitoring, and forensic science, achieving effective transformation from technology to market.

The upstream technical barriers are extremely high, and it is by no means easy to achieve mass production of nanopore gene sequencers. During the long technological R&D process, the patient capital from ZGC Development Group has helped this hard-tech enterprise accurately "decode" technical problems.

In 2019, when Qitan Tech had just completed the development of its principle prototype, ZGC Development Group intervened as a forward-looking capital and subsequently made multiple rounds of continuous investment. The Group also provided all-round services in subsequent contact with financing institutions, connection with resources in Beijing parks, and construction of production bases, helping the enterprise grow continuously.